Alpha1-antitrypsin deficiency. 2: genetic aspects of alpha(1)-antitrypsin deficiency: phenotypes and genetic modifiers of emphysema risk
about
Genes and chronic obstructive pulmonary diseaseChallenges and Prospects for Alpha-1 Antitrypsin Deficiency Gene TherapyAirway hydration and COPDNeonatal Cholestasis - Differential Diagnoses, Current Diagnostic Procedures, and TreatmentEnvironmental arsenic exposure, selenium and sputum alpha-1 antitrypsinApplication of on-line nanoLC-IT-TOF in the identification of serum β-catenin complex in mice scald modelImpact of the loss of Hoxa5 function on lung alveogenesisPolymorphism of SERPINE2 gene is associated with pulmonary emphysema in consecutive autopsy casesA comprehensive evaluation of potential lung function associated genes in the SpiroMeta general population sample.Ex vivo transduction and transplantation of bone marrow cells for liver gene delivery of alpha1-antitrypsinIntegrative genomics of chronic obstructive pulmonary disease.α₁-Antitrypsin protease inhibitor MZ heterozygosity is associated with airflow obstruction in two large cohorts.Reference and interpretive ranges for α(1)-antitrypsin quantitation by phenotype in adult and pediatric populations.Adipose tissue-derived mesenchymal stem cell-based liver gene deliveryPrevalence of α-1-antitrypsin gene mutations in Saudi Arabia.The genetics of chronic obstructive pulmonary disease.The prevalence of alpha-1 antitrypsin deficiency in IrelandDecreased expression of interleukin 13 in human lung emphysema.Immunology, genetics and microbiota in the COPD pathophysiology: potential scope for patient stratification.Glutathione S-transferase genotypes modify lung function decline in the general population: SAPALDIA cohort studyNeurotranscriptomics: The Effects of Neonatal Stimulus Deprivation on the Rat Pineal TranscriptomeRapid and inexpensive detection of alpha1-antitrypsin deficiency-related alleles S and Z by a real-time polymerase chain reaction suitable for a large-scale population-based screeningAssociation of IREB2 and CHRNA3 polymorphisms with airflow obstruction in severe alpha-1 antitrypsin deficiencyQuantitation of circulating wild-type alpha-1-antitrypsin in heterozygous carriers of the S and Z deficiency allelesAralast: an alpha 1-protease inhibitor for the treatment of alpha-antitrypsin deficiency.Results from a large targeted screening program for alpha-1-antitrypsin deficiency: 2003 - 2015.Genetic predisposition to accelerated decline of lung function in COPDNational Emphysema Treatment Trial state of the art: genetics of emphysemaScreening for Alpha 1 antitrypsin deficiency in Tunisian subjects with obstructive lung disease: a feasibility report.Ruptured Gastric Aneurysm in α-1 Antitrypsin Deficiency.Level and course of FEV1 in relation to polymorphisms in NFE2L2 and KEAP1 in the general populationDevelopment and characterization of reference materials for MTHFR, SERPINA1, RET, BRCA1, and BRCA2 genetic testing.Understanding Lung Deposition of Alpha-1 Antitrypsin in Acute Experimental Mouse Lung Injury Model Using Fluorescence MicroscopyAlpha-1 antitrypsin (AAT) deficiency - what are the treatment options?Improving diagnosis and management of alpha-1 antitrypsin deficiency in primary care: translating knowledge into action.Augmentation therapy in alpha-1 antitrypsin deficiency: advances and controversies.Lung deposition of inhaled alpha-1-proteinase inhibitor (alpha 1-PI) - problems and experience of alpha1-PI inhalation therapy in patients with hereditary alpha1-PI deficiency and cystic fibrosisMolecular diagnostics of α1-antitrypsin deficiency.Recent advances in α-1-antitrypsin deficiency-related lung disease.Detection and impact of rare regulatory variants in human disease.
P2860
Q24630805-BF5FD62A-22DC-4E65-8425-7E8853A041A0Q28080450-5B224E44-89DC-4177-BF1A-28E0F8E7533CQ28082617-52E02FDA-4158-44A4-802A-0D844D812CC9Q28083869-91567806-8B2E-4940-B1F3-121FF86AE7E6Q28385707-754AB7D0-5A21-49FA-91C7-2D747249B6EFQ28484297-C2A0CC4C-8732-41D5-AA48-C2AE2BD7738AQ28591944-025F704E-6D96-411A-B71D-528C4410255CQ33743565-30A43B70-61A0-49A0-A247-55F681FDF3E2Q33916341-F97C29A5-4349-4A91-A5D6-410C7CA4C05EQ34080880-51EFB3AC-2272-49E7-AE33-B6AA0A2115EDQ34232677-8302947F-1307-41AB-84D6-A2E9EF47859AQ34275338-A62D2555-095E-4FCC-B5BA-B6CCA38BA892Q34295276-0AC2EFDA-605D-41D8-BC80-6F25529096FEQ34810340-41DC1D4A-D1CC-474A-B6B4-FE5DF4629339Q35098361-25B411A9-0790-4346-B279-ED6ECF732AE7Q35113365-69432593-9A46-4E58-A29D-892608A70DD3Q35162540-2BC25969-2B45-4A5E-A2AA-7B2F8C050CADQ35536276-8C7FD9CD-CEA1-4550-B6D7-7A96BC83E229Q35542366-31301062-6DAD-486B-A48C-7BCC2AE8F471Q35608366-340A8EC4-3742-4BF1-9A74-08674EC0A441Q35772955-50F1E29F-80F0-4685-B57A-F8F3E44A7941Q35789532-CD54FC64-D686-4DB5-A303-9370D2CD1712Q35837259-D9844B73-0E37-4E28-8CD4-8C5A357693F7Q35937953-36730184-8D59-40A2-BFDE-DD0BA86C9FE7Q36968194-C0A9DF87-A210-40C4-8488-957D1A9D5152Q36991312-0DF24DD3-BC29-4E1E-96E4-01371625AB8DQ37017524-FD6B72EB-166E-483D-9841-C9265F635F10Q37103683-D5F31D2C-60AF-4BCB-B819-AC604042FB53Q37166417-B37337A1-0729-40CB-A30A-A3C663041323Q37246273-A404D90D-3F1A-4932-BF84-9671A187AB6FQ37334890-4FE5A0F4-61AA-41FA-A14D-EDDA6CFAF371Q37396256-92C3889E-26BA-4987-93BD-F408AF816EE4Q37516657-ABE557AD-2463-4693-A89A-A28E251D8D38Q37614554-1D468A28-9386-448F-940A-648F5246D590Q37756938-4F806148-9478-428B-AE90-8FDC22928AB4Q37774788-CA313A06-A489-45F6-ACB3-A9BBAD4329E4Q37819431-1388A9DF-E5B7-4F55-B5BC-EAD51857BF83Q38089248-AD5E777A-9A0E-46CB-91FA-F4FED45BF561Q38111790-0ED8BB8E-EB52-4AF8-832F-C6B2DEE84A3DQ38113565-5144751F-48F8-4AD3-8AC2-83A84C3615C0
P2860
Alpha1-antitrypsin deficiency. 2: genetic aspects of alpha(1)-antitrypsin deficiency: phenotypes and genetic modifiers of emphysema risk
description
2004 nî lūn-bûn
@nan
2004 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի մարտին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Alpha1-antitrypsin deficiency. ...... ic modifiers of emphysema risk
@ast
Alpha1-antitrypsin deficiency. ...... ic modifiers of emphysema risk
@en
Alpha1-antitrypsin deficiency. ...... ic modifiers of emphysema risk
@nl
type
label
Alpha1-antitrypsin deficiency. ...... ic modifiers of emphysema risk
@ast
Alpha1-antitrypsin deficiency. ...... ic modifiers of emphysema risk
@en
Alpha1-antitrypsin deficiency. ...... ic modifiers of emphysema risk
@nl
prefLabel
Alpha1-antitrypsin deficiency. ...... ic modifiers of emphysema risk
@ast
Alpha1-antitrypsin deficiency. ...... ic modifiers of emphysema risk
@en
Alpha1-antitrypsin deficiency. ...... ic modifiers of emphysema risk
@nl
P2860
P3181
P356
P1433
P1476
Alpha1-antitrypsin deficiency. ...... ic modifiers of emphysema risk
@en
P2093
E K Silverman
P2860
P304
P3181
P356
10.1136/THX.2003.006502
P407
P577
2004-03-01T00:00:00Z